Bain Capital
Leading global private investment firm with $225 billion AUM founded 1984, headquartered in Boston with 1,950+ employees investing across private equity, venture, credit, and real assets with deep vertical expertise.
Why interesting to a deal team
Co-led 2025 strategic CDMO investment in PCI confirming PE focus on pharma services consolidation; platform for margin expansion through scale and operational improvements.
Experts connected to this company
- Salim HaffarSecured 2025 strategic investment for PCI's next growth phase
- Ron CarsonSold minority stake to Bain in 2021 strategic investment
- Greg WilliamsLead investor in Acrisure's 2025 $2.1B funding round
Salim Haffar
Chief Executive Officer
PCI Pharma Services
As CEO since 2018, Haffar tripled PCI's revenue and led it through three PE ownership transitions, making him the key contact for CDMO diligence or sponsor conversations.
Ron Carson
Founder and Chairman
Carson Group
Built a $1B+ RIA aggregation platform from scratch and just handed CEO reins to a growth operator — a live case study for anyone underwriting RIA roll-ups or founder-to-professional-management transitions.
Greg Williams
Co-Founder, Chairman, and CEO
Acrisure
Founder-CEO who built Acrisure into a top-6 global broker via ~1,000 M&A deals and now controls its AI/fintech roadmap and capital strategy.
Sources
- Structured dataPrimarybaincapital.com/about-us
- Page titlePressArchived 2025-07-14businesswire.com/news/home/20250714606219/en/PCI-Pharma-Services-Enters-Next-Phase-of-Growth-With-Strategic-Investment-from-Bain-Capital-Kohlberg-and-Mubadala
- Structured dataPrimarybaincapital.com